Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115208) titled 'Validation of a Precision Screening Model for Plasma Cell Diseases Based on Routine Biochemical Parameters' on Dec. 23, 2025.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Southern Medical University Southern Hospital
Condition:
Multiple myeloma (MM)
Intervention:
M-protein negative group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2025-12-29
Target Sample Size: M-protein negative group:500;M protein positive group:1000;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=301908
Published ...